Department of Radiology, University Medical Center Regensburg, 93053, Regensburg, Germany.
Department of Radiology and Nuclear Medicine, Hospital Braunschweig, Braunschweig, Germany.
Sci Rep. 2020 Nov 2;10(1):18835. doi: 10.1038/s41598-020-75925-6.
In this study, we compare the primary efficacy of computed tomography-navigated stereotactic guidance to that of manual guidance for percutaneous microwave ablation of liver malignancies. In total, 221 patients (140, 17, and 64 with hepatocellular carcinoma, cholangiocellular carcinoma, and liver metastases, respectively) with 423 treated liver lesions underwent microwave ablation (MWA). Manual guidance (M) and stereotactic guidance (S) were used for 136 and 287 lesions, respectively. The primary endpoint was the primary efficacy and the secondary endpoint was the radiation dose. A generalised estimating equation was applied to analyse the correlation between the primary efficacy (lesion basis) and the type of guidance, size and location of lesion. The primary efficacy rate was significantly higher in the S-group (84.3%) than in the M-group (75.0%, p = 0.03). Lesion size > 30 mm was negatively correlated with the efficacy rate (odds ratio 0.38; 95% confidence interval 0.20-0.74). Stereotactic guidance was associated with a significantly lower dose length product (p < 0.01). In this retrospective study, percutaneous microwave ablation under stereotactic guidance exhibited significantly greater primary efficacy than conventional manual guidance.
在这项研究中,我们比较了计算机断层扫描导航立体定向引导与手动引导在经皮微波消融治疗肝恶性肿瘤中的主要疗效。共有 221 名患者(分别为肝细胞癌 140 例、胆管细胞癌 17 例和肝转移瘤 64 例)的 423 个肝脏病变接受了微波消融(MWA)治疗。分别使用手动引导(M)和立体定向引导(S)对 136 个和 287 个病灶进行了治疗。主要终点是主要疗效,次要终点是辐射剂量。广义估计方程用于分析主要疗效(病灶基础)与引导类型、病灶大小和位置之间的相关性。S 组(84.3%)的主要疗效率明显高于 M 组(75.0%,p=0.03)。病灶大小>30mm 与疗效呈负相关(优势比 0.38;95%置信区间 0.20-0.74)。立体定向引导与较低的剂量长度乘积相关(p<0.01)。在这项回顾性研究中,立体定向引导下的经皮微波消融显示出比传统手动引导更显著的主要疗效。